Results 61 to 70 of about 1,727,355 (121)

Maternal and infant characteristics according to maternal metabolic syndrome, at 15 weeks’ gestation.

, 2018
Maternal and infant characteristics according to maternal metabolic syndrome, at 15 weeks’ gestation.
Tina Bianco-Miotto (116492), Claire T. Roberts (103366), Shalem Y. Leemaqz (6041225), Luke E. Grzeskowiak (4268527), Lesley M. McCowan (150948), Louise C. Kenny (114837), Jessica A. Grieger (6041222), Lucilla Poston (200809), James J. Walker (441622), Gus A. Dekker (3154971), Jenny E. Myers (3213030)   +10 more
core   +1 more source

[Maternale phenylketonurie: Embryotoxiciteit in vitro van PKU bevattende metabolieten en menselijk PKU-sera.]

, 2014
Mothers with untreated phenylketonuria (PKU) have an increased risk of bearing children with congenital malformations. PKU causes accumulation of phenylalanine (PHE) and its metabolites in urine and blood, and this condition may contribute to the ...
Verhoef A, Hamers AM, van den Ham WA, Piersma AH, Jansen EHJM   +4 more
core  

The effect of maternal blood phenylalanine level on mouse maternal phenylketonuria offspring

, 1999
Maternal phenylketonuria is a disease process caused by the adverse effects of high maternal blood phenylalanine (PHE) on the fetus. Unless treated, maternal PKU results in teratogenic effects on the fetus that can lead to mental retardation ...
Chung, Sangbun
core   +2 more sources

Challenges in the management of Phenylketonuria in Malta [PDF]

, 2016
Phenylketonuria (PKU) is a rare metabolic disorder comprising a number of different enzyme deficiencies. In Malta, dihydropteridine reductase (DHPR) deficiency appears to be more common than phenylalanine hydroxylase deficiency (classical PKU), and is ...
Attard, Stephen, Attard Montalto, Simon
core  

Mealtime Anxiety and Coping Behaviour in Parents and Children during Weaning in PKU: A Case-Control Study

, 2019
Solid food introduction may create anxiety for parents of children with phenylketonuria (PKU) due to the burden associated with protein substitute (PS) administration and natural protein restriction.
Shauna Kearney, Anita MacDonald, Catherine Ashmore, Barbara Cochrane, Sharon Evans, Jo Wildgoose, Anne Daly   +6 more
core   +1 more source

Síndrome de fenilquetonuria materna, un nuevo desafío para Chile

, 2017
La fenilquetonuria (PKU) es una patología hereditaria, producida por la deficiencia o ausencia de la enzima fenilalanina hidroxilasa, lo que impide la metabolización normal de la fenilalanina (FA) a tirosina.
Peredo, Pilar, Cataldo, Ximena, Raimann, Erna, Gallardo, Sandra, Cornejo, Verónica   +4 more
core  

Characterizing Developmental Defects in an Avian Model of Maternal PKU

, 2019
Maternal phenylketonuria [MPKU] is a syndrome of multiple congenital anomalies including cardiovascular malformations [CVMs], brain and growth restriction when a mother with Phenylketonuria [PKU] does not control her dietary intake of Phenylalanine [Phe].
Canales, Jailene
core  

A pioneering transition program for adults with phenylketonuria - initial findings from a single-center one-year experience from Poland. [PDF]

Clinics (Sao Paulo)
Kania M, Pietruś M, Pawliński Ł, Orchel-Szastak K, Kwinta P, Małecki MT.   +5 more
europepmc   +1 more source

How Well Is Blood Phenylalanine Controlled in Maternal PKU in Europe? Results from 102 Pregnancies. [PDF]

Nutrients
Pinto A, Ahring K, Almeida MF, Ashmore C, Bailey S, Bélanger-Quintana A, Burlina A, Cole D, Dale C, Daly A, van Dam E, Dawson C, Evans S, Firman S, Ford S, Green D, Geberhiwot T, Hoekstra Y, Howe S, Ilgaz F, Loro C, McStravick N, Ramachandran R, Rawlins K, Robertson L, Rocha JC, Rodenburg I, Schulenburg-Brand D, van Spronsen FJ, Wilcox G, Woodall A, MacDonald A.   +31 more
europepmc   +1 more source

Phenylketonuria in Saudi Arabia: An Overview of Diagnosis, Genetics, and Therapeutic Strategies. [PDF]

Biology (Basel)
Tayeb FJ, Mir R, Alatawi S.
europepmc   +1 more source